Nebraska Pharmaceuticals Company (NPC)NPC Is Considering Whether to Make the Investment

Multiple Choice

Nebraska Pharmaceuticals Company (NPC) NPC is considering whether to make the investment today or to wait a year to find out about the FDA's decision. If it waits a year, the project's up-front cost at t = 1 will remain at $1,500, the subsequent cash flows will remain at $500 per year if the competitor's product is rejected and $25 per year if the alternative product is approved. However, if NPC decides to wait, the subsequent cash flows will be received only for six years (t = 2 ... 7) Assuming that all cash flows are discounted at 10%, if NPC chooses to wait a year before proceeding, how much will this increase or decrease the project's expected NPV in today's dollars , relative to the NPV if it proceeds today?

A) $77.23
B) $85.81
C) $95.34
D) $105.94
E) $116.53